130 related articles for article (PubMed ID: 11180117)
1. Impaired development of HIV-1 gp160-specific CD8(+) cytotoxic T cells by a delayed switch from Th1 to Th2 cytokine phenotype in mice with Helicobacter pylori infection.
Shirai M; Fujinaga R; Masaki T; Berzofsky JA
Eur J Immunol; 2001 Feb; 31(2):516-26. PubMed ID: 11180117
[TBL] [Abstract][Full Text] [Related]
2. Persistent infection by Helicobacter pylori down-modulates virus-specific CD8+ cytotoxic T cell response and prolongs viral infection.
Shirai M; Arichi T; Nakazawa T; Berzofsky JA
J Infect Dis; 1998 Jan; 177(1):72-80. PubMed ID: 9419172
[TBL] [Abstract][Full Text] [Related]
3. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance.
Actor JK; Shirai M; Kullberg MC; Buller RM; Sher A; Berzofsky JA
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):948-52. PubMed ID: 8094248
[TBL] [Abstract][Full Text] [Related]
4. Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons.
Vinner L; Nielsen HV; Bryder K; Corbet S; Nielsen C; Fomsgaard A
Vaccine; 1999 Apr; 17(17):2166-75. PubMed ID: 10367950
[TBL] [Abstract][Full Text] [Related]
5. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.
Sakaue G; Hiroi T; Nakagawa Y; Someya K; Iwatani K; Sawa Y; Takahashi H; Honda M; Kunisawa J; Kiyono H
J Immunol; 2003 Jan; 170(1):495-502. PubMed ID: 12496436
[TBL] [Abstract][Full Text] [Related]
6. Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice.
Li B; Chen L; Sun H; Yang W; Hu J; He Y; Wei S; Zhao Z; Zhang J; Li H; Zou Q; Wu C
Sci Rep; 2015 Oct; 5():14793. PubMed ID: 26434384
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of cytokine synergy essential for vaccine protection against viral challenge.
Ahlers JD; Belyakov IM; Matsui S; Berzofsky JA
Int Immunol; 2001 Jul; 13(7):897-908. PubMed ID: 11431420
[TBL] [Abstract][Full Text] [Related]
8. Expression of T-cell immunoglobulin- and mucin-domain-containing molecules-1 and -3 (Tim-1 and Tim-3) in Helicobacter pylori infection.
Hu S; Xie Y; Zhou N; Jin L; Tan Y; Liu D; Gong Y; Liu L; Liu J; Liu W; Chen Y; Zhang Y; Lv N
Helicobacter; 2011 Oct; 16(5):373-81. PubMed ID: 21923683
[TBL] [Abstract][Full Text] [Related]
9. A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques.
Mattapallil JJ; Dandekar S; Canfield DR; Solnick JV
Gastroenterology; 2000 Feb; 118(2):307-15. PubMed ID: 10648459
[TBL] [Abstract][Full Text] [Related]
10. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
[TBL] [Abstract][Full Text] [Related]
11. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load.
Mohammadi M; Nedrud J; Redline R; Lycke N; Czinn SJ
Gastroenterology; 1997 Dec; 113(6):1848-57. PubMed ID: 9394724
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry.
Klein SA; Dobmeyer JM; Dobmeyer TS; Pape M; Ottmann OG; Helm EB; Hoelzer D; Rossol R
AIDS; 1997 Jul; 11(9):1111-8. PubMed ID: 9233457
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 gp160 as a modifier of Th1 and Th2 cytokine response: gp160 suppresses interferon-gamma and interleukin-2 production concomitantly with enhanced interleukin-4 production in vitro.
Hu R; Oyaizu N; Kalyanaraman VS; Pahwa S
Clin Immunol Immunopathol; 1994 Nov; 73(2):245-51. PubMed ID: 7523014
[TBL] [Abstract][Full Text] [Related]
14. Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.
Barker E; Mackewicz CE; Levy JA
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11135-9. PubMed ID: 7479952
[TBL] [Abstract][Full Text] [Related]
15. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection.
Saldinger PF; Porta N; Launois P; Louis JA; Waanders GA; Bouzouréne H; Michetti P; Blum AL; Corthésy-Theulaz IE
Gastroenterology; 1998 Oct; 115(4):891-7. PubMed ID: 9753492
[TBL] [Abstract][Full Text] [Related]
16. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
[TBL] [Abstract][Full Text] [Related]
17. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
[TBL] [Abstract][Full Text] [Related]
18. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.
Becker Y
Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648
[TBL] [Abstract][Full Text] [Related]
19. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0.
Barnard A; Mahon BP; Watkins J; Redhead K; Mills KH
Immunology; 1996 Mar; 87(3):372-80. PubMed ID: 8778021
[TBL] [Abstract][Full Text] [Related]
20. The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine.
Kusakabe K; Xin KQ; Katoh H; Sumino K; Hagiwara E; Kawamoto S; Okuda K; Miyagi Y; Aoki I; Nishioka K; Klinman D; Okuda K
J Immunol; 2000 Mar; 164(6):3102-11. PubMed ID: 10706700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
